How effective is Mycophenolate Mofetil for Mixed Connective Tissue Disease? (a real world drug study)
Summary:
Overall ratings: 3.4/5 Long term ratings: 4/5
This is a phase IV clinical study of how effective Mycophenolate mofetil (mycophenolate mofetil) is for Mixed connective tissue disease and for what kind of people. The study is created by eHealthMe from 5 Mycophenolate mofetil users and is updated continuously.
What is Mycophenolate mofetil?
Mycophenolate mofetil has active ingredients of mycophenolate mofetil. It is often used in myasthenia gravis. eHealthMe is studying from 93,461 Mycophenolate mofetil users. Check the latest studies of Mycophenolate mofetil.
What is Mixed connective tissue disease?
Mixed connective tissue disease (an autoimmune disease, in which the body's defence system attacks itself) is found to be associated with 100 drugs and 192 conditions by eHealthMe. Check the latest studies of Mixed connective tissue disease.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
5 people are studied for taking Mycophenolate mofetil in Mixed connective tissue disease
Overall effectiveness (number of people):
Long term (1+ years) effectiveness (number of people):
Mycophenolate mofetil effectiveness for Mixed connective tissue disease (number of people):
Overall:
- not at all: 0
- somewhat: 2
- moderate: 1
- high: 0
- very high: 2
Long Term:
- not at all: 0
- somewhat: 1
- moderate: 0
- high: 0
- very high: 2
Gender of people who take Mycophenolate mofetil for Mixed connective tissue disease *:
- female: 60 %
- male: 40 %
Age of people who take Mycophenolate mofetil for Mixed connective tissue disease *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 20 %
- 30-39: 20 %
- 40-49: 20 %
- 50-59: 40 %
- 60+: 0.0 %
Who find Mycophenolate Mofetil more effective for Mixed Connective Tissue Disease?
Gender of people who take Mycophenolate mofetil for Mixed connective tissue disease *:
- female: 50 %
- male: 50 %
Age of people who take Mycophenolate mofetil for Mixed connective tissue disease *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 50 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 50 %
- 60+: 0.0 %
* Approximation only. Some reports may have incomplete information.
Do you take Mycophenolate mofetil?
- You can start a phase IV clinical trial to monitor Mycophenolate mofetil safety and effectiveness.How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related studies
Alternative drugs to, pros and cons of:
- Mycophenolate mofetil (93,461 reports)
Treatments, associated drugs and conditions:
- Mixed connective tissue disease (2,085 reports)
How the study uses the data?
The study is based on mycophenolate mofetil (the active ingredients of Mycophenolate mofetil) and Mycophenolate mofetil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Valacyclovir cause Escherichia Infection? - 6 seconds ago
- Drug interactions of Mupirocin and Zinc Chloride - 8 seconds ago
- Drug interactions of Sulfasalazine and Thiamine Mononitrate - 10 seconds ago
- Could Atorvastatin Calcium cause Dry Skin? - 11 seconds ago
- Could Lonsurf cause Deep Venous Thrombosis? - 13 seconds ago
- Could Estring cause Intervertebral Disc Degeneration? - 16 seconds ago
- Could Arava cause Hepatitis Chronic Active? - 17 seconds ago
- Could Tranxene cause Dehydration? - 17 seconds ago
- Could Fludara cause Idiopathic Pneumonia Syndrome? - 20 seconds ago
- Drug interactions of Flexeril and Cipro - 21 seconds ago